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Abstract
Asthma is a chronic reversible obstructive airway disease, which is common among children and leads to respiratory impairment.
Studies showed that asthma is more common among children born after in vitro fertilization (IVF) than among spontaneously
conceived children. However, it is unknown which component of the IVF procedure contributes to this putative link. Therefore,
the aim of this prospective follow-up study was to differentiate the possible effect of ovarian hyperstimulation from that of the
in vitro culture procedure on asthma and rhinitis in 9-year-old children conceived with IVF. The study comprised three groups of
singletons: (I) conceived with ovarian hyperstimulation-IVF (COH-IVF, n = 95); (II) conceived with modified natural cycle-IVF
(MNC-IVF, n = 48); and (III) naturally conceived to subfertile couples (Sub-NC, n = 68). Parents filled out the validated Dutch
version of the asthma questionnaire of the International Study of Asthma and Allergies. Asthma prevalence in the groups did not
differ: COH-IVF n = 8 (8%);MNC-IVF n = 0 (0%); and Sub-NC n = 4 (6%). Adjustment for confounders did not alter the results.
Conclusion: Neither ovarian hyperstimulation nor the in vitro culture procedure was associated with asthma and rhinitis at
9 years. IVF children had a similar prevalence of asthma compared with children conceived naturally by subfertile couples.
Trial registration: ISRCTN76355836
What is Known:
• An increased risk for asthma has been observed in children born after in vitro fertilization at preschool and school age.
• The association between IVF and asthma may be partly explained by parental subfertility.
What is New:
• IVF children do not have a higher prevalence of asthma than children of subfertile couples conceived naturally.
• Ovarian hyperstimulation used in IVF is not associated with asthma in 9-year-old children of subfertile couples.
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Abbreviations
AUMC Amsterdam University Medical Center
COH Controlled ovarian hyperstimulation
ISAAC International Study of Asthma and Allergies
MNC Modified natural cycle
PIAMA Prevention and Incidence of Asthma
and Mite Allergy
PGS Preimplantation genetic screening
Sub-NC Subfertile-naturally conceived
TTP Time to pregnancy
UMCG University Medical Center Groningen
Introduction
Worldwide, over 8 million children are conceived after in vitro
fertilization (IVF) [4]. The short-term effects of IVF on chil-
dren’s health have been studied comprehensively [13].
Overall, studies were reassuring; nevertheless, singletons con-
ceived after IVF were more often born preterm and had a
lower birthweight compared with natural conceived single-
tons [6]. Recently, studies increasingly address the possible
effects of IVF on child health in later life [6]. One of the main
points of interest of these studies is to clarify whether there is
an association between IVF and atopic disease, including asth-
ma and rhinitis [6]. Asthma is a chronic reversible obstructive
airway disease, which is common among children and leads to
coughing, wheezing, and breathing difficulties.
Recent studies found an increased risk for asthma in IVF
offspring, independent from gestational age and birthweight
[2, 5, 8, 9]. However, it is not clear yet which element of the
IVF procedure (the in vitro culture procedure and/or ovarian
hyperstimulation) may contribute to this putative link.
Ovarian hyperstimulation induces the growth of multiple fol-
licles, bypassing the natural selection of the development of
one dominant follicle, and leads to higher oestrogen levels
preceding the laboratory IVF procedures. During the in vitro
culture procedure oocytes, sperm and embryos are handled
outside the human body, possibly affecting their developmen-
tal phenotype. As it is known that the early environment of an
embryo affects its physiology and thereby may lead to a
higher risk for diseases in later life, it is conceivable ovarian
stimulation and the in vitro culture procedure affect the health
of the offspring [15]. Others suggested a link between parental
subfertility and asthma in IVF offspring [7].
Therefore, the aim of this study was to disentangle the
effect of ovarian hyperstimulation from that of the in vitro
culture procedure independently from the effect subfertility
on asthma and rhinitis in 9-year-old children. To this end,
we compared three groups: (i) singletons conceived with con-
trolled ovarian hyperstimulation-IVF (COH-IVF); (ii) single-
tons conceived with modified natural cycle-IVF (MNC-IVF);
and (iii) naturally conceived singletons born to subfertile
couples (Sub-NC). COH-IVF is the conventional form of
IVF in which ovarian hyperstimulation is used. In MNC-
IVF, the one follicle that naturally developed to dominance
is used: no ovarian hyperstimulation is performed. The Sub-
NC group comprised of children of all couples who achieved a
singleton pregnancy while on the waiting list for fertility eval-
uation or treatment during the study period and wanted to
participate in the study. These couples had been trying to
conceive for at least 1 year; therefore, we expected parental
characteristics to resemble the characteristics of IVF couples.
Differences between the COH-IVF and MNC-IVF group
can be attributed to the effect of ovarian hyperstimulation.
Comparing the MNC-IVF and Sub-NC group reveals the ef-
fect of the in vitro culture procedure.
Methods
Study design
The children participated in two parallel prospective studies: the
Groningen assisted reproductive techniques (ART) cohort study
and the preimplantation genetic screening (PGS) trial [10, 11].
The Groningen ARTcohort study is a prospective assessor-
blinded longitudinal follow-up study, which focuses on devel-
opmental outcomes and health of IVF offspring. The cohort
started with subfertile couples who consulted the Department
of Reproductive Medicine of the University Medical Center
Groningen (UMCG). Couples with an expected delivery date
betweenMarch 2005 and December 2006 were invited during
the third trimester of pregnancy to participate in the study. The
singletons formed the following three groups: (i) COH-IVF,
(ii) MNC-IVF, and (iii) Sub-NC [11].
The PGS trial is a multicenter randomized controlled trial
(Amsterdam University Medical Center (AUMC) and UMCG)
comparing IVF with and without PGS. Women who received
help conceiving by means of IVF at the Departments of
Reproductive Medicine of the AUMC or UMCG between
May 2003 and November 2005 were recruited [10]. Of the
PGS trial, only those singletons who were conceived after
COH-IVF without PGS (i.e. the control group) were eligible
to participate in the current study. Twins, children born after
oocyte cryopreservation and oocyte or embryo donation, were
excluded. Information on the prenatal, neonatal, and perinatal
period was collected on standardized charts 2 weeks after the
expected delivery date. This included parental asthma,maternal
BMI, smoking during pregnancy, and smoking in the house-
hold. The effect of the duration of subfertility was evaluated
with the help of the proxy variable time to pregnancy (TTP).
Information about TTP was retrieved from the medical file of
the couples. In case of miscarriage TTP can be < 1 year, as TTP
has a new onset [11].
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At the 9-year follow-up assessment, parents filled out the
validated Dutch adaption of the questionnaire used in the
International Study of Asthma and Allergies (ISAAC), which
was previously used in the Dutch national birth cohort
Prevention and Incidence of Asthma and Mite Allergy
(PIAMA) [1, 16]. The medical ethics committee of the
UMCG approved the study design of the 9-year follow-up
of the Groningen ART cohort study and PGS trial (reference
number M09.074824; current controlled trial number,
ISRCTN76355836) and parents provided written informed
consent.
Outcome measures asthma and rhinitis
The ISAAC questionnaire consists of questions about asthma,
eczema, and rhinitis. Consistent with the asthma definition as
defined by international experts in the Mechanisms of the
Development of Allergy (MEDALL) study, asthma was defined
as a positive response to at least two out of the three questions on
asthma: (I) Did your child ever have asthma?; (II) Did your child
have wheezing complaints in the past 12 months?; and (III) Did
your child use asthmamedication in the past 12months? Rhinitis
was defined as a positive answer to two specific questions in the
questionnaire: (I) In the past 12 months, has your child had a
problemwith sneezing, or a running, or a blocked nose when he/
she DID NOT have a cold or the flu? and (II) In the past
12 months, has this nose problem been accompanied by itchy-
watery eyes? (for detailed information, see Asher et al. 1995 and
Pinart et al. 2014) [1, 12].
Statistical analysis
The original power calculation of the Groningen ART cohort
study was based on neurological outcome at the age of
18 months. Our study was initially not designed to investigate
the prevalence of asthma and rhinitis.
To estimate differences in background and outcome charac-
teristics, univariable and multivariable statistics were used. The
multivariable regression analyses adjusted for the following con-
founders: at least one parent with asthma, a currently smoking
parent, birthweight, maternal body mass index, and TTP. The
confounders were selected on a priori bases and in keeping with
the literature [6, 13]. Results are expressed as odds ratio (OR)
with 95% confidence interval (95% CI). The analyses were per-
formed in SPSS Statistics version 20.0 (IBM Corp, NY, USA).
Results
Participation and parental and infant characteristics
Of the Groningen ART cohort study, 58 COH-IVF, 48 MNC-
IVF, and 68 Sub-NC children participated. Of the PGS trial,
37 COH-IVF singletons took part in the study. This means that
we assessed in total: COH-IVF n = 95, MNC-IVF n = 48, and
Sub-NC n = 68 children (see supporting information flow
chart). Overall, postnatal attrition was 22% and was nonselec-
tive. We did not find differences between the COH-IVF group
of the Groningen ART cohort and the PGS trial regarding
background and outcome characteristics.
The characteristics of participating parents and children of the
three study groups are displayed in Table 1. Parents of COH-IVF
singletons were older than those in the MNC-IVF and Sub-NC
groups. In the two IVF groups, TTP was longer (COH-
IVF4.0 years; MNC-IVF3.8 years) compared with the Sub-NC
group (2.0 years). The underlying cause of parental subfertility in
the IVF groups was more often paternal, whereas in the Sub-NC
group, it was more often unexplained. Gestational age was
shorter and birthweight was lower in the COH-IVF group than
in the Sub-NC group. Singletons in the MNC-IVF group were
more often small-for-gestational age compared with COH-IVF
singletons. The rate of folic acid use was higher in theMNC-IVF
group than in the Sub-NC group.
Asthma and rhinitis
Table 2 presents the asthma and rhinitis data. Asthma preva-
lence did not differ between the three groups. In the COH-IVF
group 8 (8%), in the MNC-IVF group 0 (0%), and in the Sub-
NC 4 (6%), children had asthma. The prevalence of asthma
medication use also did not differ between the three groups.
Adjustment for confounders did not alter the results (Table 3).
The frequency of rhinitis ever and current rhinitis was sim-
ilar in the three groups. After correction for confounders, rhi-
nitis occurred more often in the Sub-NC group than in the
MNC-IVF group. Hay fever did differ between the groups: it
occurred more often in the COH-IVF group (15%) and Sub-
NC group (15%) than in the MNC-IVF group (2%). This
group difference in hay fever between the three groups
remained after adjustment for confounders (Table 3).
Additional adjustment for breastfeeding longer than 6 weeks,
Caesarean section, maternal age, and the use of a high dose of
folic acid (≥ 5 mg) did not alter the results.
Discussion
This prospective follow-up study suggests that asthma and
rhinitis in 9-year-old childrenwere not associatedwith ovarian
hyperstimulation or the in vitro culture procedure.
Our current findings at 9 years of age differ from with
our follow-up data at the age of 4 years. At 4 years, we
found that children born following COH-IVF more often
used asthma medication than naturally conceived children
of subfertile couples [8]. At that time, however, we did
not use a standardized and validated questionnaire, but
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focused on the use of asthma medication and asthma-
related symptoms. As recurrent respiratory symptoms such
as cough and wheeze are highly prevalent in that age
group, as they also occur during viral respiratory tract
infections, asthma at age 4 is difficult to diagnose.
Therefore, we interpret the results obtained in our current
follow-up study as more valid.
Carson et al. used the ISAAC questionnaire to assess asth-
ma prevalence and asthmamedication use in 5- and 7-year-old
IVF children and naturally conceived children of fertile and
subfertile couples in the Millennium Cohort Study (n =
18,818) in the UK [2]. They reported an increased prevalence
of asthma in 5-year-old children born after ART (adjusted OR
(95% CI)—2.38 (1.34, 4.24)). At 7 years, the effect had
Table 1 Characteristics of participating parents and children
Characteristics COH-IVF (n = 95) MNC-IVF (n = 48) Sub-NC (n = 68)
Parental characteristics
Maternal age at conception, median (range) 35.9 (27.0–41.0)*/# 32.9 (26.2–37.5)* 33.5 (23.1–40.3)#
Paternal age at conception, median (range) 36.7 (27.5–59.3)*/# 34.2 (28.3–47.8)* 35.4 (25.5–48.7)#
Education level mother high, n (%)a,b 43 (45) 21 (44) 32 (47)
Maternal BMI before pregnancy, median (range)a 23.6 (17.9–42.5) 23.1 (16.8–30.6) 23.2 (18.0–46.7)
≥ 1 parent with asthma, n (%) 3 (3) 3 (6) 6 (9)
≥ 1 currently smoking parent, n (%) 22 (23) 18 (38) 18 (27)
Fertility parameters
TTP in years, median (range) 3.9 (0.1–13.3)# 3.8 (0.1–7.5)^ 2.0 (0.1–11.3)#/^
ICSI, n (%) 54 (56) 23 (48) n.a.
Maternal subfertility, n (%) 36 (38) 15 (31) 19 (28)
Paternal subfertility, n (%) 48 (51)*/# 26 (54)* 18 (26)#
Unexplained subfertility, n (%) 18 (19)*/# 8 (17)* 36 (58)#
Gestational characteristics
Smoking during pregnancy, n (%) 8 (9) 5 (10) 7 (10)
Caesarean section, n (%) 27 (28) 8 (17) 19 (28)
Use of folic acid during pregnancy, n (%) 83 (91) 48 (100)^ 59 (87)^
The use of high folic acid ≥ 5 mg, n (%) 10 (11) 5 (10) 2 (3)
Birth characteristics
Gestational age in weeks, median (range) 39.4 (33.4–42.3)# 39.8 (34.6–42.6) 40.0 (30.1–42.6)#
Preterm birth (< 37 weeks), n (%) 7 (7) 6 (13) 4 (6)
Birthweight in grams, mean (σ) 3385 (573)# 3390 (594) 3591 (513)#
Low birthweight, n (%) 4 (4) 4 (8) 2 (3)
Small-for-gestational age, n (%) 0 (0)* 3 (6)* 1 (2)
Neonatal characteristics
NICU admission, n (%) 2 (2) 2 (4) 4 (6)
Apgar score at 5 min < 7, n (%)a 1 (1) 0 (0) 0 (0)
Breastfed for > 6 weeks, n (%)a 40 (56) 22 (46) 34 (51)
Child characteristics
Male sex, n (%) 51 (54) 22 (46) 34 (50)
Firstborn, n (%)b 62 (65) 34 (71) 40 (59)
Age at examination in years, median (range) 9.2 (9.0–9.7) 9.2 (9.0–10.7) 9.2 (8.4–9.9)
Statistically significant differences (p < 0.05) are displayed in bold. The symbols denote which groups differ significantly from each other (asterisks: * ;
carets: ^ ; and hashtags: # ). Values are number (percentage), mean (standard deviation (σ)), or median (range)
BMI body mass index, COH-IVF controlled ovarian hyperstimulation-IVF, ICSI intracytoplasmic sperm injection, MNC-IVF modified natural cycle-
IVF, n.a. not available, NICU neonatal intensive care unit, Sub-NC naturally conceived children born to subfertile couples, TTP time to pregnancy
aMissing data in the COH-IVF group: breastfed for > 6 weeks n = 23; education level father high n = 3; maternal BMI n = 5; paternal age at conception
n = 14; smoking during pregnancy n = 2; the use of high folic acid ≥5 mg n = 4; use of folic acid during pregnancy n = 4. Missing data in the MNC-IVF
group: Apgar score 5 min < 7 n = 1, paternal age at conception n = 1. Missing data in the Sub-NC group: Apgar score 5 min < 7 n = 1; breastfed for >
6 weeks n = 1; education level father high n = 1
bHigher vocational education or university education
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Table 2 Asthma and rhinitis at
9 years in the three study groups COH-IVF (n = 95) MNC-IVF (n = 48) Sub-NC (n = 68)
Asthma
Asthma ever, n (%) 11 (12) 2 (4) 7 (10)
If so, diagnosed by physician, n (%) 11 (12) 2 (4) 7 (10)
Wheezing complaints last year, n (%) 5 (5) 0 (0) 3 (4)
Asthma medication use last year, n (%) 8 (8) 0 (0) 2 (3)
Current asthma, n (%) 8 (8) 0 (0) 4 (6)
Rhinitis
Rhinitis ever, n (%) 24 (25) 9 (19) 19 (28)
Rhinitis in the past year, n (%) 22 (23) 7 (15) 16 (24)
From February to May, n (%) 4 (4) 0 (0) 1 (1)
From May to August, n (%) 2 (2) 1 (2) 4 (6)
All year, n (%) 5 (5) 0 (0) 3 (4)
No indications of months, n (%) 11 (12) 6 (13) 8 (12)
With itchy-watery eyes, n (%) 7 (7) 1 (2) 8 (12)
Interfering with daily activities, n (%) 6 (6) 2 (4) 2 (3)
Hay fever ever, n (%) 14 (15)* 1 (2)*/# 10 (15)#
Current rhinitis, n (%) 7 (7) 1 (2) 8 (12)
Statistically significant differences (p < 0.05) are displayed in bold; the symbols denote which groups differ
significantly from each other (asterisks: * and hashtags: # ). Values are number (percentage)
COH-IVF controlled ovarian hyperstimulation-IVF, MNC-IVF modified natural cycle-IVF, Sub-NC naturally
conceived children born to subfertile couples
Table 3 Multiple regression analysis of the effect of ovarian hyperstimulation, the in vitro procedure, and a combination of these two on asthma and
rhinitis
COH-IVF vs. MNC-IVF MNC-IVF vs. Sub-NC COH-IVF/ICSI vs. Sub-NC
Adjusted OR (95% CI) p value Adjusted OR (95% CI) p value Adjusted OR (95% CI) p value
Asthma
Asthma ever 3.32 (0.65, 16.9) 0.148 0.18 (0.03, 1.21) 0.077 0.91 (0.29, 2.84) 0.911
If so, diagnosed by physician xx xx xx xx xx xx
Wheezing complaints last year xx xx xx xx 0.88 (0.17, 4.53) 0.877
Asthma medication use last year xx xx xx xx 2.47 (0.46, 13.4) 0.294
Current asthma xx xx xx xx 1.30(0.32, 5.24) 0.709
Rhinitis
Rhinitis ever 1.79 (0.72, 4.45) 0.213 0.91 (0.38, 2.14) 0.823 0.84 (0.39, 1.83) 0.668
Rhinitis in the past year 4.41 (0.38, 50.7) 0.402 2.16 (0.25, 18.48) 0.484 3.22 (0.38, 27.4) 0.284
From February to May xx xx xx xx xx xx
From May to August 0.36 (0.53, 8.45) 0.528 0.32 (0.02, 4.22) 0.387 0.27 (0.03, 2.30) 0.427
All year xx xx xx xx 2.36 (0.34, 16.2) 0.762
No indications of months 0.17 (0.02, 1.86) 0.147 10.49 (0.57, 194.5) 0.115 0.63 (0.13, 3.02) 0.563
With itchy-watery eyes 4.02 (0.23, 70.5) 0.341 0.10 (0.01, 2.19) 0.145 0.41 (0.09, 1.95) 0.260
Interfering with daily activities 1.06 (0.08, 14.2) 0.963 3.14 (0.04, 252.2) 0.609 2.30 (0.31, 17.1) 0.416
Hay fever, ever 9.59 (1.16, 79.0) 0.036 0.20 (0.01, 0.64) 0.020 1.04 (0.39, 2.82) 0.932
Current rhinitis 4.37 (0.45, 42.2) 0.203 0.09 (0.01, 0.90) 0.039 0.48 (0.14, 1.62) 0.237
In the adjusted analyses, we corrected for a currently smoking parent, at least one parent with asthma, birthweight, maternal bodymass index, and time to
pregnancy. Statistically significant differences (p < 0.05) are displayed in bold
COH-IVF controlled ovarian hyperstimulation-IVF, MNC-IVF modified natural cycle-IVF, Sub-NC naturally conceived children born to subfertile
couples
a Some confidence intervals were maximal width owing to the small numbers in the cells. Results should therefore be interpreted with caution
b The symbol ‘xx’ denotes that numbers were too small for regression analysis
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decreased (adjusted OR (95% CI)—1.84 (1.03, 3.28)). It
should be noted that in the 5-year-data, the authors adjusted
for, among other things, gestational age, Caesarean section,
and breastfeeding, whereas in the 7-year-data, such an adjust-
ment was not performed. No adjustment was made for low
birthweight which is a known risk factor for the development
of asthma [2, 5]. In addition, Carson and colleagues found
some evidence that subfertility is associated with an increased
risk of asthma. Our study suggests that both IVF components,
ovarian hyperstimulation, and in vitro culture procedures are
not associated with asthma and asthma medication use.
This finding is in line with Källén et al., who used asthma
medication as an outcome parameter recorded in a large
Swedish birth register cohort aged 2 to 25 years (n =
2,628,728). Their data indicated that the association between
IVF and asthma was mainly caused by the underlying fertility
problems, rather than by IVF [7]. In addition, the study did not
adjust for some risk factors known to be associated with the
development of asthma such as low birthweight.
The prevalence of asthma of 0–8% (overall 6%) in our
study is somewhat lower than the 11% reported in the Dutch
PIAMA study (n = 3963) in children aged 7–8 years [3]. Also,
Carson et al. reported lower prevalences than in their general
population, which was attributed to the favourable back-
ground characteristics of IVF couples, such as higher educa-
tional attainment [2]. This also holds true for our study. The
favourable background in our study groups is also reflected in
their living conditions: according to their postal codes, they
lived in areas with very low rates of air pollution [14]. Still the
current prevalences of asthma, hay fever, and rhinitis are re-
markably low. This underlines the notion that our study
groups are not representative of the general population.
Strengths of our study are the use of the validated ISAAC-
based questionnaire and the study’s design which allows to
separately evaluate the effect of the in vitro culture procedure
and ovarian hyperstimulation on child health. The subfertile
control group (Sub-NC group) prevents overestimation of the
effect of IVF.
A number of caveats need to be discussed regarding the
present study. Firstly, the size of the three groups is relatively
small (illustrated by the broad confidence intervals), especial-
ly the MNC-IVF group. This prevents us from drawing firm
conclusions and excluding a type II error. However, other
studies investigating the effect of IVF on asthma in the off-
spring do not have the ability to study the effect of ovarian
hyperstimulation and the in vitro culture procedure separately.
Secondly, the absence of a fertile control group precludes a
conclusion on the effect of the subfertility. With the couples’
TTP, we have detailed information on the duration of
subfertility. TTP was included as a confounder in the regres-
sion analyses, thus making sure that our results were not con-
founded by the severity of subfertility. However, due to the
lack of a group of children born to fertile couples, we are not
able to address the impact of subfertility per se on asthma in
the offspring, and therefore, we cannot rule out a potential
effect of parental subfertility on the offspring’s risk for asthma.
In conclusion, our study suggests that ovarian hyperstimula-
tion, the in vitro culture procedure, and a combination of these
two in IVF with hyperstimulation are not associated with asthma
and rhinitis at 9 years of age. The previously found association
between COH-IVF and asthma (use of asthma medication) at
4 years of age could not be replicated at age 9. In addition, our
data suggest that IVF offspring does not have a higher prevalence
of asthma than children of subfertile couples conceived naturally.
As ARTs are still increasingly used, it is of importance that a
meta-analysis and future studies further investigate the effect of
parental subfertility and the different aspects of IVF on child
health, including asthma and rhinitis.
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